{
  "DOI": "10.1038/s41431-022-01262-z",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01262-z",
  "alternative-id": [
    "1262"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "5 October 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "25 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "29 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "12 December 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-7476-6867",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nijenhuis",
      "given": "Marga",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Soree",
      "given": "Bianca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jama",
      "given": "Wafa O. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Boer-Veger",
      "given": "Nienke J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buunk",
      "given": "Anne Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Houwink",
      "given": "Elisa J. F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rongen",
      "given": "Gerard A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Schaik",
      "given": "Ron H. N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3965-5552",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1429-4789",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Touw",
      "given": "Daan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Weide",
      "given": "Jan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2298-9924",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van Westrhenen",
      "given": "Roos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deneer",
      "given": "Vera H. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Risselada",
      "given": "Arne",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        12,
        12
      ]
    ],
    "date-time": "2022-12-12T06:02:59Z",
    "timestamp": 1670824979000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        12,
        1
      ]
    ],
    "date-time": "2023-12-01T01:02:53Z",
    "timestamp": 1701392573000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        4
      ]
    ],
    "date-time": "2024-04-04T07:48:52Z",
    "timestamp": 1712216932495
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2022,
        12,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            12
          ]
        ],
        "date-time": "2022-12-12T00:00:00Z",
        "timestamp": 1670803200000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            12
          ]
        ],
        "date-time": "2022-12-12T00:00:00Z",
        "timestamp": 1670803200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01262-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01262-z",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01262-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1364-1370",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        12,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        12,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1371/journal.pmed.0040209",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "e209",
      "journal-title": "PLoS Med",
      "key": "1262_CR1",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H, De Vries EG, Assendelft WJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR2",
      "unstructured": "Swen JJ, Wilting I, de Goede AL, Grandia L, Mulder H, Touw DJ, et al. Pharmacogenetics: from bench to byte. Clin Pharm Ther. 2008;83:781–7.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR3",
      "unstructured": "Swen JJ, Nijenhuis M, van Rhenen M, De Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic information in clinical guidelines: the European perspective. Clin Pharm Ther. 2018;103:795–801.",
      "volume": "103",
      "year": "2018"
    },
    {
      "key": "1262_CR4",
      "unstructured": "European Association for Clinical Pharmacology and Therapeutics (EACPT). Available from: https://www.eacpt.eu/. [Accessed November 2017]."
    },
    {
      "key": "1262_CR5",
      "unstructured": "European Association of Hospital Pharmacists (EAHP). Available from: https://www.eahp.eu/. [Accessed November 2017]."
    },
    {
      "DOI": "10.1002/cpt.911",
      "author": "U Amstutz",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR6",
      "unstructured": "Amstutz U, Henricks LM, Offer SM, Barbino J, Schellens JHM, Swen JJ, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update. Clin Pharm Ther. 2018;103:210–6.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "PC Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR7",
      "unstructured": "Bank PC, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, et al. Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharm Ther. 2018;103:599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR8",
      "unstructured": "Swen JJ, Nijenhuis M, De Boer BA, Grandia L, Maitland-van der Zee AH, Mulder H. et al. Pharmacogenetics: from bench to byte - an update of guidelines. Clin Pharm Ther. 2011;89:662–73.",
      "volume": "89",
      "year": "2011"
    },
    {
      "key": "1262_CR9",
      "unstructured": "Royal Dutch Pharmacists Association (KNMP): Pharmacogenetic Recommendation Text. Available from: https://www.knmp.nl/. [Accessed April 2022]."
    },
    {
      "DOI": "10.1038/s41431-019-0540-0",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Eur J Hum Genet",
      "key": "1262_CR10",
      "unstructured": "Lunenburg CATC, van der Wouden CH, Nijenhuis M, Crommentuijn-van Rhenen MH, de Boer-Veger NJ, Buunk AM, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines. Eur J Hum Genet. 2020;28:508–17.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-021-00920-y",
      "author": "M Matic",
      "doi-asserted-by": "publisher",
      "first-page": "1105",
      "journal-title": "Eur J Hum Genet",
      "key": "1262_CR11",
      "unstructured": "Matic M, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Hum Genet. 2022;30:1105–13.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-021-01004-7",
      "author": "JMJL Brouwer",
      "doi-asserted-by": "publisher",
      "first-page": "1114",
      "journal-title": "Eur J Hum Genet",
      "key": "1262_CR12",
      "unstructured": "Brouwer JMJL, Nijenhuis M, Soree B, Guchelaar HJ, Swen JJ, van Schaik RHN, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. Eur J Hum Genet. 2022;30:1114–20.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1177/1060028013510699",
      "author": "A Sharma",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "journal-title": "Ann Pharmacother",
      "key": "1262_CR13",
      "unstructured": "Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother. 2014;48:209–25.",
      "volume": "48",
      "year": "2014"
    },
    {
      "author": "BT Felt",
      "first-page": "456",
      "journal-title": "Am Fam Physician",
      "key": "1262_CR14",
      "unstructured": "Felt BT, Biermann B, Christner JG, Kochhar P, Harrison RV. Diagnosis and management of ADHD in children. Am Fam Physician. 2014;90:456–64.",
      "volume": "90",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S2215-0366(18)30269-4",
      "author": "S Cortese",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "Lancet Psychiatry",
      "key": "1262_CR15",
      "unstructured": "Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5:727–38.",
      "volume": "5",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fpsyt.2021.780921",
      "author": "D Fu",
      "doi-asserted-by": "publisher",
      "first-page": "780921",
      "journal-title": "Front Psychiatry",
      "key": "1262_CR16",
      "unstructured": "Fu D, Wu DD, Guo HL, Hu YH, Xia Y, Ji X, et al. The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for ADHD therapy in children: a narrative review. Front Psychiatry. 2022;12:780921.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.2165/00003088-199937060-00002",
      "author": "HC Kimko",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Clin Pharmacokinet",
      "key": "1262_CR17",
      "unstructured": "Kimko HC, Cross JT, Abernethy DR. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet. 1999;37:457–70.",
      "volume": "37",
      "year": "1999"
    },
    {
      "DOI": "10.1089/cap.2013.0028",
      "author": "F Sallee",
      "doi-asserted-by": "publisher",
      "first-page": "308",
      "journal-title": "J Child Adolesc Psychopharmacol",
      "key": "1262_CR18",
      "unstructured": "Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013;23:308–19.",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1111/cts.12692",
      "author": "KE Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "journal-title": "Clin Transl Sci",
      "key": "1262_CR19",
      "unstructured": "Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, Klein TE, et al. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group. Clin Transl Sci. 2020;13:116–24.",
      "volume": "13",
      "year": "2020"
    },
    {
      "key": "1262_CR20",
      "unstructured": "National Center for Biotechnology Information. COMT catechol-O-methyltransferase [Homo sapiens (human)] (2022). https://www.ncbi.nlm.nih.gov/gene/1312. [Accessed 24 February 2022]."
    },
    {
      "author": "A Napolitano",
      "first-page": "35",
      "journal-title": "J Neural Transm Suppl",
      "key": "1262_CR21",
      "unstructured": "Napolitano A, Cesura AM, Da Prada M. The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm Suppl. 1995;45:35–45.",
      "volume": "45",
      "year": "1995"
    },
    {
      "DOI": "10.1097/00008571-199606000-00007",
      "author": "HM Lachman",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Pharmacogenetics",
      "key": "1262_CR22",
      "unstructured": "Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–50.",
      "volume": "6",
      "year": "1996"
    },
    {
      "DOI": "10.1021/bi00013a008",
      "author": "T Lotta",
      "doi-asserted-by": "publisher",
      "first-page": "4202",
      "journal-title": "Biochemistry",
      "key": "1262_CR23",
      "unstructured": "Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;4:4202–10.",
      "volume": "4",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0006-3223(99)00098-0",
      "author": "MA Palmatier",
      "doi-asserted-by": "publisher",
      "first-page": "557",
      "journal-title": "Biol Psychiatry",
      "key": "1262_CR24",
      "unstructured": "Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry. 1999;46:557–67.",
      "volume": "46",
      "year": "1999"
    },
    {
      "key": "1262_CR25",
      "unstructured": "gnomAD browser. Gene: COMT. (2022). https://gnomad.broadinstitute.org/gene/ENSG00000093010?dataset=gnomad_r2_1."
    },
    {
      "DOI": "10.1155/2014/591717",
      "author": "C Huppertz",
      "doi-asserted-by": "publisher",
      "first-page": "591717",
      "journal-title": "Biomed Res Int",
      "key": "1262_CR26",
      "unstructured": "Huppertz C, Bartels M, Groen-Blokhuis MM, Dolan CV, de Moor MH, Abdellaoui A, et al. The dopaminergic reward system and leisure time exercise behavior: a candidate allele study. Biomed Res Int. 2014;2014:591717.",
      "volume": "2014",
      "year": "2014"
    },
    {
      "key": "1262_CR27",
      "unstructured": "US label Strattera 25-2-2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021411s049lbl.pdf."
    },
    {
      "key": "1262_CR28",
      "unstructured": "UK Summary of Product Characteristics Ritalin 6-7-2021. https://www.medicines.org.uk/emc/product/1035/smpc."
    },
    {
      "key": "1262_CR29",
      "unstructured": "UK Summary of Product Characteristics clonidine hydrochloride Accord 7-12-2021. https://www.medicines.org.uk/emc/product/5030/smpc."
    },
    {
      "DOI": "10.1097/01.chi.0000246056.83791.b6",
      "author": "D Michelson",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "journal-title": "J Am Acad Child Adolesc Psychiatry",
      "key": "1262_CR30",
      "unstructured": "Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J. CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007;46:242–51.",
      "volume": "46",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrd3921",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Nat Rev Drug Disco",
      "key": "1262_CR31",
      "unstructured": "Pirmohamed M, Hughes DA. Pharmacogenetic tests: the need for a level playing field. Nat Rev Drug Disco. 2013;12:3–4.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1038/clpt.2010.310",
      "author": "RB Altman",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR32",
      "unstructured": "Altman RB. Pharmacogenomics: “noninferiority” is sufficient for initial implementation. Clin Pharm Ther. 2011;89:348–50.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ejca.2015.11.008",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Eur J Cancer",
      "key": "1262_CR33",
      "unstructured": "Lunenburg CATC, Henricks LM, Guchelaar HJ, Swen JJ, Deenen MJ, Schellens JHM, et al. Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time. Eur J Cancer. 2016;54:40–8.",
      "volume": "54",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.1409",
      "author": "JT Brown",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "journal-title": "Clin Pharm Ther",
      "key": "1262_CR34",
      "unstructured": "Brown JT, Bishop JR, Sangkuhl K, Nurmi EL, Mueller DJ, Dinh JC, et al. Clinical Pharmacogenetics Implementation Consortium guideline for cytochrome P450 (CYP)2D6 genotype and atomoxetine therapy. Clin Pharm Ther. 2019;106:94–102. https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/",
      "volume": "106",
      "year": "2019"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-2134851/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01262-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "31"
}